Cannabis Life Network

OCTOBER 14, 2021

Even as a common name, CBG had yet to undergo the same tests and clinical trials as CBD to ensure high doses are safe. The post CBG is safe, gets green light for clinical trials and therapy appeared first on Latest Cannabis News Today - Headlines, Videos & Stocks.

Clinical Trials 120

Clinical Trials Therapy Cannabinoids CBD 120

Veriheal

JUNE 17, 2021

However, there has not been a clinical trial assessing the efficacy of cannabis for migraines, at least not until now. Science Alert has announced that the first clinical trial for cannabis as a migraine treatment is underway. The First Clinical Trial for Migraines and Cannabis.

Clinical Trials 98

Clinical Trials Treatment Patients Cannabis 98

Cannabis Law Report

MAY 26, 2021

MindMed (Nasdaq: MNMD) announced today that its clinical trial plans to evaluate the acute effects of serotonergic hallucinogen mescaline have… Read More.

Clinical Trials 98

Clinical Trials 98

Cannabis Life Network

NOVEMBER 18, 2020

announced early this morning that it will undertake a clinical trial of psilocybin-assisted psychotherapy. The compassionate access clinical trial will enable the company to refine optimal protocols for the use of psilocybin-assisted psychotherapy for participants with a range of substance use disorders.

Clinical Trials 92

Clinical Trials Access Therapy Events 92

Project CBD

JUNE 19, 2019

The launch of a clinical trial examining the use of CBD in newborns suffering from hypoxic ischemic encephalopathy (brain damage caused by lack of oxygen) means new hope for the million plus babies born each year with this condition. Giving medical cannabis to infants is a difficult taboo to shift, but new research is paving the way.

Clinical Trials 273

Clinical Trials CBD Conditions Cannabis 273

Project CBD

MARCH 2, 2020

Recently NIDA supported a clinical trial which used nicotine as a therapy for relatively mild cannabis withdrawal symptoms.

Clinical Trials 268

Clinical Trials Therapy Recreational Cannabis 268

Cannabis Law Report

JULY 21, 2021

The study is expected to be the world’s first Phase 2a clinical trial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinical trial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.

Clinical Trials 105

Clinical Trials Chronic Pain Research and Development Treatment 105

NORML

DECEMBER 18, 2020

This study’s primary outcome supports the theory that cannabis should be [tested in clinical trials] as a potential therapeutic for PTSD.". “This study provides evidence that the types of cannabis available in recreational and medical cannabis dispensaries might hold promise as an alternative treatment for PTSD.

Clinical Trials 246

Clinical Trials Patients Treatment Dispensary 246

Cannabis Law Report

AUGUST 10, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today reported that its subsidiary Oravax Medical Inc. Oravax”), partially owned with its majority partner Oramed Pharmaceuticals Inc.

Clinical Trials 105

Clinical Trials Pharmaceutical Research and Development CBD 105

Cannabis Law Report

JANUARY 17, 2021

The post NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials first appeared on Cannabis Law Report. We hope he does a better job than some of the playlists we’ve seen recently ! NeonMind Biosciences Inc. … Read More.

Clinical Trials 97

Clinical Trials Programs Law Cannabis 97

Project CBD

OCTOBER 10, 2019

Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials. Pharmaceutical researchers have their sights set on developing a drug that bypasses CB1 while boosting CB2.

Cannabinoids 227

Cannabinoids Clinical Trials Research and Development Pharmaceutical 227

NORML

JULY 25, 2022

The Act provides the office of the US Attorney General with a 60-day timeline to either approve or deny the applications from scientists wishing to engage in clinical trials involving the use of cannabis by human subjects.

Legislation 227

Legislation Clinical Trials Cannabis 227

Americans for Safe Access

JUNE 2, 2020

This new agency, the Office of Medical Cannabis Control (OMCC), would be tasked with overseeing not only the requirements of the research program, but would also enable cultivators that are already licensed in medical cannabis states to provide high quality medical cannabis to researchers, thereby increasing the diversity of products that can be used (..)

Clinical Trials 264

Clinical Trials DEA History Programs 264

NORML

APRIL 30, 2020

” This finding is hardly a surprise, as cannabis is well-established to mitigate pain in clinical models, particularly in patients with neuropathy. According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5 percent in 2016).”

Chronic Pain 329

Chronic Pain Clinical Trials Data Patients 329

Cannabis Law Report

JUNE 7, 2021

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.

Clinical Trials 81

Clinical Trials Patients THC Safety 81

Cannabis Law Report

JUNE 29, 2021

We look forward to his expertise as we expand our mental health analytical platform and enter clinical trials. ramps up to begin clinical trials by adding esteemed medical professional to its medical advisory board. Research in the area of mental health has been Dr. Nitin Desai’s passion. ” About Ehave, Inc.

Clinical Trials 105

Clinical Trials Research and Development Data Patients 105

NORML

JULY 26, 2019

Federal officials have approved plans for the University of Mississippi to grow 2,000 kilograms (4,409 pounds) of cannabis to provide to investigators for clinical trial research. Clinicians wishing to conduct FDA-approved clinical trials on cannabis have long complained that federally-provided samples are of inferior quality.

Clinical Trials 194

Clinical Trials Marijuana Strains THC 194

NORML

JANUARY 17, 2019

A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. Click here to send a message to your Representative and urge them to support the measure. .

Clinical Trials 221

Clinical Trials Legislation DEA Patients 221

Puff Puff Post

MARCH 10, 2020

InMed and CHDR are currently preparing the Clinical Trial Application for a second Phase 1 clinical trial (755-102-HV), planned to begin in the second quarter of 2020, which will examine the local safety of INM-755 on small areas of wounded skin in healthy volunteers.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

NORML

MARCH 30, 2020

By contrast, they reported that there exists “no evidence from properly designed clinical trials to support the use of CBD for the treatment” of these or other conditions, such as the flu, West Nile virus, Ebola, or common cold viruses. However, this data was based solely on preclinical findings.

CBD 287

CBD Clinical Trials Data Treatment 287

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. Los Angeles, California. www.InvestorBrandNetwork.com. 310.299.1717 Office.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

AUGUST 24, 2021

Nasdaq:HUGE) (CSE:HUGE) (FRA:0K9) (the “ Company ” or “ FSD ”) announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide (“PEA”), or FSD-201, for use in treating COVID-19. TORONTO–(BUSINESS WIRE)–FSD Pharma Inc.

Clinical Trials 81

Clinical Trials Treatment Pharmaceutical Concentrates 81

NORML

DECEMBER 6, 2019

The transdermal application of plant-derived CBD reduces fascial pain in patients with temporomandibular disorders (TMD aka TMJ), according to clinical data published in the Journal of Clinical Medicine.

Clinical Trials 106

Clinical Trials Patients CBD Therapy 106

NORML

APRIL 8, 2020

The National Organization for the Reform of Marijuana Laws (NORML) has formally submitted comments to the US Federal Register opposing the Drug Enforcement Administration’s proposed rule changes governing the federal production and distribution of cannabis for clinical research purposes.

Cultivation 340

Cultivation DEA Clinical Trials Marijuana 340

NORML

JANUARY 31, 2019

Proposed federal legislation to direct the agency to conduct clinical trials on the use of cannabis for PTSD and for other conditions is currently pending in the US House and Senate. Twenty percent of those surveyed acknowledged having previously used cannabis for medical purposes.

Clinical Trials 204

Clinical Trials Chronic Pain Data Treatment 204

Cannabis Law Report

JUNE 30, 2023

Food and Drug Administration (FDA or Agency) on June 23, 2023, released its first draft guidance concerning design and desired features of clinical trials for psychedelic drugs LSD and MDMA There has been growing interest in studying the use of psychedelic drugs for […]

Clinical Trials 52

Clinical Trials Food 52

Leafly

SEPTEMBER 15, 2020

In order for a prescription drug to reach the market, it must be extensively studied, first in animal and then in human clinical trials. Safety, efficacy, and risks must be determined. But as anyone who has seen a commercial for a prescription drug knows, there are still side effects. There are risks in stopping a […].

Clinical Trials 145

Clinical Trials Safety Cannabis 145

Medical Marijuana Program Connection

JUNE 9, 2023

var mantis = mantis || []; mantis.push(['display', 'load', { property: '5bbb53a2bcafb20075d8dc64' }]); A drug aimed at treating marijuana addiction has shown early promise in clinical trials as cannabis use has…

Clinical Trials 52

Clinical Trials Marijuana Cannabis 52

NORML

APRIL 15, 2019

Clinicians wishing to conduct FDA-approved clinical trials on cannabis have long complained that federally-provided samples are of inferior quality. .” A separate study published in 2017 reported that U-Miss samples contain far lower levels of both THC and CBD than do commercially available cannabis.

Hemp 196

Hemp Clinical Trials Marijuana Programs 196

FloridaMarijuana.net

AUGUST 16, 2018

The clinical trials for medications take years and to this date, there have been no effective medications to properly treat and/or cure Dementia. Globally, the number of older adults (aged 65 years and older) is projected to increase even more dramatically — more than doubling from 420 million in 2000 to 973 million in 2030.

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

Cannabis Law Report

JUNE 2, 2021

Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. None of it was initially slated to go to clinical trials. The deadline for proposals is Friday, July 16. Read more at.

Clinical Trials 105

Clinical Trials Marijuana Recreational Collective 105

Cannabis Law Report

AUGUST 22, 2021

Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Presently, the company is working with researchers to build out these technologies and pave the way for clinical trials. Silo Pharma Inc. Looking to the Future. Silo Pharma Inc.

Clinical Trials 105

Clinical Trials Research and Development Safety Treatment 105

Cannabis Law Report

AUGUST 23, 2021

Phase I clinical trial of the Satipharm CBD capsules in which results demonstrated the safety and high performance of the oral capsule technology, including the superior delivery profile of cannabidiol (CBD) compound to trial subjects. Here’s the mindless blurb.

Clinical Trials 105

Clinical Trials CBD Epilepsy Treatment 105

NORML

MARCH 1, 2019

.” He later acknowledged that these restrictions have led many “companies [to] go overseas to conduct research with foreign-grown product that is more easily sourced for the purposes of clinical trials.” ” Although that ruling ordered DEA to lift the ban, the agency failed to do so.

DEA 194

DEA Research and Development Clinical Trials Marijuana 194

Cannabis Law Report

JULY 23, 2021

“When you’re talking about wanting to do an actual clinical trial, you need a diversity of people that participate and one state just does not have the diversity of people that are required,” Towle said. The new DEA research license will now change that.

DEA 105

DEA Clinical Trials Cannabinoids Extraction 105

Leafly

OCTOBER 4, 2022

A drug that blocks the brain's cannabinoid receptors is now in clinical trials and showing promising results. The post Are you too high? A promising new ‘comedown drug’ may be on the way appeared first on Leafly.

Clinical Trials 106

Clinical Trials Cannabinoids Medicine THC 106

The Fresh Toast

JULY 22, 2020

Clinical trial results indicate cannabis could provide an alternative or adjunctive treatment to sickle cell patients. Marijuana Shows Promise In Sickle Cell Disease Treatment. The post Marijuana Shows Promise In Sickle Cell Disease Treatment appeared first on The Fresh Toast.

Treatment 105

Treatment Clinical Trials Marijuana Patients 105